Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETAP study of angiotensin II response in formerly preeclamptic women
NL-OMON26813Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label trial of Angiotensin II in preeclampsia (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Renal response to angiotensin II after low- and high-sodium diet. Started Mar 2011; status: active, not recruiting.
02
Drugs
Angiotensin II
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NL-OMON26813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26813.